Large unmet clinical needs are driving demand for better transseptal access to the left heart

The rapid development of transcatheter therapies for atrial fibrillation and heart disease has seen a shift in the importance of transseptal puncture as a route to the left heart.

affected individuals
Global Transseptal Access Systems

These clinical needs have strong procedural growth and are driving a ~$2B transseptal access market opportunity

Market Drivers

  • Aging population
  • Growing prevalence of heart disease
  • Global healthcare access
  • Increasing diagnostic access
  • Innovations in Interventional Cardiology & Electrophysiology (TEER, TMVR, TMVr, LAAC, Cryo, PFA)